Full site launching summer 2026 · In development
Announcing the merger of RNA Advisors & RLS Consultants

From value assessment
to value creation.

RNA Advisors and Rosenblatt Life Science Consultants are now unified under The REVA Group — combining investor-grade valuation and transaction advisory with pharma-grade forecasting, analytics, primary research, and an AI-native platform built for life sciences intelligence.

Stay in the loop

Or reach us directly at info@revagroupls.com

One Group · Three Engines A brief introduction

Senior advisory calibrates every output. An AI-native platform scales the work.

Biotech teams get one engine from value assessment to value creation. Three operating brands, one unified analytical process.

i.
a REVA Group Company

RNA Advisors

Senior-led valuation, transaction, and strategic advisory.

ii.
a REVA Group Company

RLS Consultants

Pharma management science, analytics, and decision support.

iii.
AI-Native · Coming Soon

REVA Platform

Productized intelligence — purpose-built for biotech.

Our Mission

To boldly & disruptively bring institutional-grade intelligence to every early-stage biotech — the investor lens of RNA Advisors, the pharma lens of RLS Consultants, and the REVA Platform in one integrated group.

— The REVA Group, on the merger thesis